动态功能连接性MEG阿尔茨海默病的特征
Huaqing Jin1, Kamalini G Ranasinghe2, Pooja Prabhu1
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
NeuroImage
|September 12, 2023
概括
动态大脑网络复杂性,通过状态过渡和自身模式来衡量,有效地区分阿尔茨海默病 (AD) 和对照. 这种新的方法揭示了阿尔茨海默病患者的改变时间和空间动态,提供了新的诊断见解.
科学领域:
- 神经科学是一个神经科学.
- 脑部成像 脑部成像
- 网络科学 网络科学
背景情况:
- 休息状态功能连接 (RSFC) 研究通常分析静态的大脑网络,忽视动态,时间变化的活动.
- 动态RSFC特征与神经退行性疾病 (如阿尔茨海默氏症) 之间的关联尚不清楚.
- 现有的动态RSFC分析方法在可靠提取疾病特征方面存在局限性.
研究的目的:
- 调查动态功能连接特征是否与阿尔茨海默病 (AD) 有关.
- 引入和验证一种新的变时动态网络 (TVDN) 方法来提取动态RSFC特征.
- 评估动态网络特征在区分AD患者与健康对照中的诊断潜力.
主要方法:
- 利用了来自AD患者的高分辨率磁脑电图 (MEG) 数据和匹配的对照.
- 应用了一种新的时间变动动态网络 (TVDN) 算法来提取动态RSFC特征,包括时间和空间复杂性.
- 将TVDN衍生特征的诊断性能与现有基准进行了比较.
主要成果:
- 动态多重特征,特别是时间复杂性 (状态转换,停留时间) 和空间复杂性 (自身模式),对AD的高度预测.
- 与现有方法相比,TVDN方法在区分AD与健康受试者方面表现出更高的灵敏度和特异性.
- 与对照组相比,AD患者的空间复杂性明显高,时间复杂性较低.
- 来自TVDN的动态图形理论指标在AD和对照组之间存在显著差异,与静态指标不同.
结论:
- 动态RSFC特征,特别是与网络复杂性相关的特征,在阿尔茨海默病中受到显著影响.
- TVDN方法提供了一种强大的方法来识别神经退行性疾病中的动态大脑网络变化.
- 这些发现表明,动态连接模式对于了解阿尔茨海默病理生理学至关重要,并可能作为有价值的生物标志物.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.大脑状态开关大脑状态开关痴呆症是一种痴呆症.动态静止状态 动态静止状态功能连接性的功能连接性.功能性磁共振是一种功能性磁共振.磁性脑电图 (MEG) 是一种磁性脑电图.多模式成像技术多模式成像技术更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.0K
08:36Dynamic Inter-subject Functional Connectivity Reveals Moment-to-Moment Brain Network Configurations Driven by Continuous or Communication Paradigms
Published on: March 21, 2019
7.3K
相关概念视频
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
